Johnson Matthey (JMAT)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 17.2 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 4.11 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Mar | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | TTM | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Last ex-div: 28th Nov, paid: 5th Feb more... Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | +7.9% | |||||||||
FINANCIAL BRIEF: For the six months ended 30 September 2012, Johnson Matthey PLC revenues decreased 17% to L4.89B. Net income decreased 2% to L146.3M. Revenues reflect Precious Metals segment decrease of 21% to L3.34B, Environmental Tecnology segment decrease of 8% to L1.41B, Catalysts & Chemicals segment decrease of 2% to L142.1M. Net income also reflects Precious Metals segment income decrease of 33% to L71.8M. Dividend per share remained flat at L0.16. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 30th Sep '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 2 | 5 | 4 | 3 |
Johnson Matthey Plc is a global specialty chemicals company operating in three divisions: Environmental Technologies, Precious Metal Products and Fine Chemicals. Environmental Technologies is a supplier of catalysts and related technologies for applications, such as pollution control, cleaner fuel, hydrocarbons and the hydrogen economy. Precious Metal Products’ activities comprise the marketing, distribution, refining and recycling of platinum group metals (pgms), fabrication of products using precious metals and related materials, manufactures pgm and base metal catalysts and pgm chemicals. Fine Chemicals is a supplier of active pharmaceutical ingredients, fine chemicals and other specialty chemical products and services to chemical and pharmaceutical industry’s customer supplier of catalysts. In March 2012, Endo Pharmaceuticals Holdings Inc. acquired U.S. patent 7,851,482 B2 for oxymorphone hydrochloride from the Company. In March 2013, the Company acquired Formox AB.
Directors: Niel Carson (CEO) 55, Robert MacLeod (Fin. Dir.) , Larry Pentz (Exec. Dir.) 57, W. Sandford (Exec. Dir.) 59, Simon Farrant (Secy.) ,
No. of Employees: 10,058 No. of Shareholders: 10,376
| Last Annual | March 31st, 2012 |
| Last Interim | September 30th, 2012 |
| Shares in Issue | 204,916,577 |
| Free Float | 198.0m (96.6%) |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | FTSEUROFIRST 300 , E300 ex EURO COR, FTSE 350 Act , FTSE Lower Yield , FT350 Chemicals , FTSE 100 , FTSE 100 Eod Gbp , |
| Exchange |
London Stock Exchange (Full) |
| Eligible for | an ISA? a SIPP? |
| Address | 5th Floor,25 Farringdon Street, LONDON, EC4A 4AB, United Kingdom |
| Web | |
| Phone | +44 20 72698400 |
| Contact | Ian Godwin (IR Contact Officer) |
| Registrar | Lloyds TSB Registrars (Sussex) |
| Auditors | KPMG Audit PLC |
| Tue 4:52pm | Director/PDMR Shareholding |
| Tue 11:03am | Holding(s) in Company |
| Mon 11:05am | Directorate Change |
| Fri 3:24pm | Director/PDMR Shareholding |
| 9th May | Director/PDMR Shareholding |
| 29th Apr | Director/PDMR Shareholding |
Recent ↓
